![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
You’re operating at a high level. Now let’s make sure it stays that way.
Your results show that your organization has built something most health systems are still working toward: a functioning, integrated specialty pharmacy and infusion strategy with real operational momentum behind it. That’s not a small thing.
The Mature phase is about something different than what got you here. It’s not about building or scaling anymore. It’s about staying ahead of a market that doesn’t slow down, reducing the variability that’s crept in as you’ve grown, and making sure your enterprise is ready for what’s coming next, not just what’s in front of you today.
Where you are today
Your organization is in the Mature phase, which means you’ve moved through the work of building and scaling and you’re now focused on optimizing performance and staying ahead of the market. That’s a fundamentally different challenge, and it requires a fundamentally requires a different kind of strategic alignment.
At this stage, the question isn’t whether your strategy is working. It’s whether it will keep working as the market shifts, as new therapies launch, as payer dynamics evolve, and as the complexity of running specialty and infusion at enterprise scale starts to compound.
The goal now is to move from reactive to proactive, to reduce variability across your system, and to make sure you’re prepared for what’s next, not just what’s now.
What health systems at this stage typically experience:
- Inconsistent performance across sites: What works well in one location doesn’t always translate across the enterprise. Variability in outcomes, workflows, and financial performance creates drag that’s hard to see and harder to fix without the right visibility.
- Reactive decision-making under market pressure: Payer shifts, biosimilar launches, therapy changes, market evolution. At this stage, reacting to change is costly. The organizations that are best prepared are the ones who see it coming and have a plan ready.
- Fragmented strategy at the therapy and site level: Biosimilar decisions made site by site. Inconsistent economics across infusion and specialty settings. Launch fatigue. These aren’t execution failures, they’re signs of a system that’s grown faster than its governance structures.
- The complexity of staying ahead at scale: You’ve built something significant. Keeping it optimized, keeping it competitive, and keeping it ready for the next chapter of specialty and infusion, that’s the challenge in front of you now.
Stay ahead of the market. Reduce variability. Prepare for what’s next.
Here’s what we’ve learned from health systems at this stage: the biggest risk isn’t falling behind overnight. It’s drifting, gradually, through a thousand small decisions that weren’t made with the full picture in mind. The focus now is on building the structures and the foresight that keep that from happening.
Move from insight to foresight
Benchmarking and longitudinal trend data let you anticipate payer shifts, therapy changes, and market evolution before they hit. The goal is to make decisions ahead of the market, not in response to it.
Standardize and optimize performance system-wide
Establish standard KPIs across sites, build multi-site governance structures, and close the performance gaps that have opened up as you’ve scaled. Consistency at this stage is a competitive advantage.
Build a coordinated biosimilar strategy
Fragmented biosimilar decisions by site, product, or payer are one of the most common sources of financial performance variability at this stage. A single, coordinated strategy across specialty and infusion, with clear economics and repeatable launch execution, changes that.
Optimize your therapy mix and long-term site-of-care strategy
Margin performance, therapy mix optimization, expanded payer contract access, and a clear long-term view of where care should be delivered. These are the levers that separate mature health systems from truly differentiated ones.
Expect more. Achieve more.
You’ve built something most health systems are still working toward. Our team will reach out personally to help you protect that advantage, close the performance gaps, and make sure your organization is positioned for whatever comes next.
If you’d like to move faster, we’d love to set up a discovery call to walk through your results and map out exactly where to focus first.